The combination of the insidious nature of PA’s disease progression, the accepted association of AIG with neuroendocrine tumors, and a focus on Hp as the major risk factor for gastric adenocarcinoma may have contributed to a lack of appreciation for the gastric cancer risk associated with AIG. This evidence concerns the gene HP and neuroendocrine neoplasm.